Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 4/20 | 0.37 |
| ▸ | TACR1 | P25103 | 7/20 | 0.34 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.34 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.34 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.31 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.30 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
| ▸ | BCR | P11274 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22157280 | 0.97 | TGFBR1 (0.37) | TGFBR1TACR1SGMS1SGMS2TOP1 | |
| SCHEMBL22157285 | 0.94 | TGFBR1 (0.37) | TGFBR1TACR1SGMS1SGMS2TOP1 | |
| SCHEMBL22157643 | 0.91 | TGFBR1 (0.37) | TGFBR1TACR1SGMS1SGMS2TOP1 | |
| SCHEMBL22157287 | 0.91 | TGFBR1 (0.39) | TGFBR1SGMS1SGMS2TOP1TDP1 | |
| SCHEMBL22156752 | 0.89 | TGFBR1 (0.37) | TGFBR1TACR1SGMS1SGMS2TOP1 | |
| SCHEMBL22157617 | 0.88 | KIF11 (0.37) | TACR1TDP1 | |
| SCHEMBL22156026 | 0.88 | CYP11B1 (0.36) | TACR1TDP1KDM1A | |
| SCHEMBL22157736 | 0.88 | TGFBR1 (0.36) | TGFBR1TOP1TDP1MAPKAPK2ASIC3 | |
| SCHEMBL22157886 | 0.86 | TGFBR1 (0.33) | TGFBR1SGMS1SGMS2ASIC3 | |
| SCHEMBL22157606 | 0.85 | KIF11 (0.40) | TACR1TDP1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | TGFBR1 2276/4885TACR1 936/4885SGMS1 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.